New York – June 3, 2013 – The Cardiovascular Research Foundation (CRF) announced today that Ori Ben-Yehuda, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center (CTC). As Executive Director, Dr. Ben-Yehuda will be responsible for all CTC activities. The CTC is a full-service academic research organization, providing expert physician project leadership, comprehensive clinical trial design, data management and biostatistical analyses, numerous core laboratory services, event adjudication, and safety reporting functions. Dr. Ben-Yehuda will take over for Helen Parise, ScD who will be assuming a new role in the CTC as Chief Statistical Officer and Director of the Data Coordinating Center within the CTC.

Dr. Ben-Yehuda is a distinguished clinical cardiologist and co-author of numerous scientific publications in top tier medical journals. Most recently, Dr. Ben-Yehuda was Vice President, Cardiovascular Clinical Research at Gilead Sciences. Prior to that, he was Professor of Clinical Medicine at the University of California, San Diego and the Director of the Coronary Care Unit at UCSD Medical Center. Dr. Ben-Yehuda also served as the Deputy Editor of the Journal of the American College of Cardiology.

"We are excited to welcome Dr. Ben-Yehuda who will substantially strengthen the capabilities and expertise of the CRF Clinical Trials Center," said Gregg W. Stone, MD, Co-Director of the Medical Research and Education Division at CRF. "Dr. Ben-Yehuda's extensive clinical experience, coupled with his expert knowledge of clinical trial design and research, will broaden our expertise in leading important pharmaceutical studies, as well as enhance our current proficiencies in device-based cardiovascular trials. We would also like to recognize and thank Helen Parise for her expert interim leadership of the CTC during the past year and a half," said Dr. Stone.

"I am delighted to join the CRF Clinical Trials Center, an organization with a distinguished reputation for innovation and contributions in cardiovascular medicine and patient care," said Dr. Ben-Yehuda. "Working closely with CRF's distinguished physician leadership, I hope to expand the CTC's expertise in clinical trial design and development."